Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

January 15, 2005 (Vol. 25, No. 2)

Microfluidics Technology Goes Mainstream

Biotech & Pharma Firm Appreciate Standardized Assay Formats

  • It has taken little more than a decade for microfluidics-based systems to become accepted and integrated into drug discovery by Big Pharma companies such as Merck, J&J, Pfizer, Lilly, Tashio, Amgen, Novartis, Serono, and Aventis. Microfluidics emerged in the 1990s as a branch of physics and biotechnology that ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.